» Articles » PMID: 35523579

Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms

Abstract

Background: The pathophysiology of AKI during tumor lysis syndrome (TLS) is not well understood due to the paucity of data. We aimed to decipher crystal-dependent and crystal-independent mechanisms of TLS-induced AKI.

Methods: Crystalluria, plasma cytokine levels, and extracellular histones levels were measured in two cohorts of patients with TLS. We developed a model of TLS in syngeneic mice with acute myeloid leukemia, and analyzed ultrastructural changes in kidneys and endothelial permeability using intravital confocal microscopy. In parallel, we studied the endothelial toxicity of extracellular histones RESULTS: The study provides the first evidence that previously described crystal-dependent mechanisms are insufficient to explain TLS-induced AKI. Extracellular histones that are released in huge amounts during TLS caused profound endothelial alterations in the mouse model. The mechanisms of histone-mediated damage implicates endothelial cell activation mediated by Toll-like receptor 4. Heparin inhibits extracellular histones and mitigates endothelial dysfunction during TLS.

Conclusion: This study sheds new light on the pathophysiology of TLS-induced AKI and suggests that extracellular histones may constitute a novel target for therapeutic intervention in TLS when endothelial dysfunction occurs.

Citing Articles

Tumour lysis syndrome.

Howard S, Avagyan A, Workeneh B, Pui C Nat Rev Dis Primers. 2024; 10(1):58.

PMID: 39174582 DOI: 10.1038/s41572-024-00542-w.


Allopurinol use leading to xanthine nephrolithiasis in pediatric tumor lysis syndrome: a case series.

Goswami S, Hanson A, Rajadhyaksha E, Dangle P, Schwaderer A Pediatr Nephrol. 2024; 39(11):3217-3219.

PMID: 38842722 DOI: 10.1007/s00467-024-06413-6.


Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database.

Li Z, Guo C, Liu X, Qiu Z, Zhang R Front Pharmacol. 2024; 15:1368763.

PMID: 38549677 PMC: 10972959. DOI: 10.3389/fphar.2024.1368763.


Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia.

Attieh R, Begum F, Chitty D, Izzedine H, Jhaveri K Kidney Med. 2024; 6(2):100769.

PMID: 38313809 PMC: 10837097. DOI: 10.1016/j.xkme.2023.100769.


Proteomic Analysis on Sequential Samples of Cystic Fluid Obtained from Human Brain Tumors.

Magrassi L, Brambilla F, Vigano R, Silvestre D, Benazzi L, Bellantoni G Cancers (Basel). 2023; 15(16).

PMID: 37627098 PMC: 10452907. DOI: 10.3390/cancers15164070.